Cite
Wang JW, Ma L, Liang Y, et al. RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1α-XBP1s pathway. Cell Death Discov. 2021;7(1):298doi: 10.1038/s41420-021-00696-6.
Wang, J. W., Ma, L., Liang, Y., Yang, X. J., Wei, S., Peng, H., Qiu, S. P., Lu, X., Zhu, Y. Q., & Wang, B. L. (2021). RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1α-XBP1s pathway. Cell death discovery, 7(1), 298. https://doi.org/10.1038/s41420-021-00696-6
Wang, Jia-Wei, et al. "RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1α-XBP1s pathway." Cell death discovery vol. 7,1 (2021): 298. doi: https://doi.org/10.1038/s41420-021-00696-6
Wang JW, Ma L, Liang Y, Yang XJ, Wei S, Peng H, Qiu SP, Lu X, Zhu YQ, Wang BL. RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1α-XBP1s pathway. Cell Death Discov. 2021 Oct 18;7(1):298. doi: 10.1038/s41420-021-00696-6. PMID: 34663798; PMCID: PMC8523720.
Copy
Download .nbib